4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001437749-25-028705
General Counsel sold 1,520 shares at $19.11 ($29,047)
- General Counsel acquired 3,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Smith Jason Drew · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-07 | Exercise or conversion : show line 1 in the form | +3,333 | 44,825 | D | ||
| 2025-09-08 | Sale : show line 2 in the form | −1,520 | $19.11 | $29,047 | 43,305 | D |
| Open-market sales · 1,520 sh · avg $19.11 · $29,047 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-07 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −3,333 | 3,334 | D |
Loading xslF345X05/rdgdoc.xml…